Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_assertion description "[The aim of this study was to evaluate whether the neoadjuvant use of the dexamethasone (DEX) plus octreotide (OCT) regimen can improve the direct anticancer effects of docetaxel (DOC) in the TRAMP-C1 prostate cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_assertion evidence source_evidence_literature NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_assertion SIO_000772 22210719 NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_assertion wasDerivedFrom befree-20150227 NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_assertion wasGeneratedBy ECO_0000203 NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP873567.RA8U9Eq6UZmkxjx9j2NCPtwEkQPKt-LZyvWBlvoUqtrgM130_provenance.